ALP Antibody (Rabbit mAb) [B19A18]

製品コード:F5591

印刷

生物学的記述

Specificity ALP Antibody (Rabbit mAb) [B19A18] detects endogenous levels of total ALP protein.
Background ALP belongs to the PDZ-LIM family of actin-associated scaffold proteins, structurally defined by an N-terminal PDZ domain and a C-terminal LIM domain that together mediate direct binding to α-actinin. ALP colocalizes with α-actinin at the Z-discs of striated muscle, where the PDZ-LIM architecture links the protein to the actin-binding surface of the α-actinin spectrin-repeat region, positioning ALP as a structural scaffold rather than an enzymatic regulator. ALP expression rises sharply during myogenic differentiation, and disruption of ALP expression reduces transcript levels of the muscle regulatory factors myogenin and MyoD, placing ALP function upstream of the core myogenic transcriptional program. Loss of ALP causes a marked reduction in organized actin filament bundles within differentiating muscle cells, and this cytoskeletal disruption directly suppresses the activity of serum response factor, a transcription factor whose activation depends on actin polymerization state and the nuclear availability of its coactivator MAL. Restoring MyoD expression in ALP-depleted cells is sufficient to rescue myogenic differentiation despite persistent actin bundle loss, indicating that ALP acts through the actin-SRF-MyoD axis to control entry into the differentiation program rather than through a parallel independent pathway. Treatment with an actin-stabilizing compound restores SRF activity and differentiation capacity in ALP-depleted cells, reinforcing that ALP's contribution to myogenesis operates through maintenance of filamentous actin architecture. PDZ-LIM family members, including ALP, interact with the CH and spectrin-repeat domains of α-actinin isoforms across muscle and non-muscle contexts, supporting roles in both Z-disc stability and, in emerging evidence, actin-dependent membrane trafficking. Z-disc scaffold proteins of this family, including ALP, are implicated in the structural integrity of cardiac and skeletal sarcomeres, with disruption linked to cardiomyopathy susceptibility in genetic association studies.

使用情報

Application WB, IHC Dilution
WB IHC
1:500-1:1000 1:1000
Reactivity Human
Source Rabbit Monoclonal Antibody MW 39 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

References

  • https://pubmed.ncbi.nlm.nih.gov/38095060/
  • https://pubmed.ncbi.nlm.nih.gov/17332502/

Application Data